Bifeprunox:: A new atypical antipsychotic with in vivo, agonistic activity at the 5-HT1A receptor

被引：0
|
作者：
Hertel, P
Husum, H
Marquis, K
Herremans, AHJ
Hesselink, MB
机构：
来源：
SCHIZOPHRENIA RESEARCH | 2006年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [21] Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT2A receptors: functional receptor-binding and in vivo electrophysiological studies
    Arlene D. Stark
    Shaun Jordan
    Kelly A. Allers
    Robert L. Bertekap
    Ruoyan Chen
    Tanaz Mistry Kannan
    Thaddeus F. Molski
    Frank D. Yocca
    Trevor Sharp
    Tetsuro Kikuchi
    Kevin D. Burris
    Psychopharmacology, 2007, 190 : 373 - 382
  • [22] Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT2A receptors:: functional receptor-binding and in vivo electrophysiological studies
    Stark, Arlene D.
    Jordan, Shaun
    Allers, Kelly A.
    Bertekap, Robert L.
    Chen, Ruoyan
    Kannan, Tanaz Mistry
    Molski, Thaddeus F.
    Yocca, Frank D.
    Sharp, Trevor
    Kikuchi, Tetsuro
    Burris, Kevin D.
    PSYCHOPHARMACOLOGY, 2007, 190 (03) : 373 - 382
  • [23] The 5-HT1A receptor in schizophrenia:: a promising target for novel atypical neuroleptics?
    Bantick, RA
    Deakin, JFW
    Grasby, PM
    JOURNAL OF PSYCHOPHARMACOLOGY, 2001, 15 (01) : 37 - 46
  • [24] Human 5-HT1A receptor occupancy after a single dose of a putative atypical antipsychotic MDL 100,907.
    Grunder, G
    Yokoi, F
    Offord, SJ
    Salzmann, JK
    Krasenbaum, DN
    Szymanski, S
    Ravert, HT
    Dannals, RF
    Wong, DF
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 439 - 439
  • [25] Partial 5-HT1A receptor agonistic properties of (-)pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo
    Arborelius, L
    Linnér, L
    Wallsten, C
    Ahlenius, S
    Svensson, TH
    NORDIC JOURNAL OF PSYCHIATRY, 2000, 54 (02) : 92 - 92
  • [26] 5-HT1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine
    Assie, MB
    Cosi, C
    Koek, W
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 334 (2-3) : 141 - 147
  • [27] The importance of 5-HT1A receptor agonism in antipsychotic drug action: Rationale and perspectives
    Newman-Tancredi, Adrian
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (07) : 802 - 812
  • [28] Preferential in vivo action of F15599, a novel 5-HT1A receptor agonist, at postsynaptic 5-HT1A receptors
    Llado-Pelfort, L.
    Assie, M-B
    Newman-Tancredi, A.
    Artigas, F.
    Celada, P.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (08) : 1929 - 1940
  • [29] Functional effects of corticosterone on 5-HT1A and 5-HT1B receptor activity in rat brain:: in vivo microdialysis studies
    Gur, E
    Dremencov, E
    Lerer, B
    Newman, ME
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 411 (1-2) : 115 - 122
  • [30] Fingolimod activates the 5-HT1A receptor in S1P3R/5-HT1A heterooligomer complexes in vivo
    Opiteck, G. J.
    Scott, F. L.
    Meadows, K. R. Taylor
    Dines, K.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 493 - 493
12345